Children's Center for Rehabilitation Hospital
Oklahoma City, Oklahoma, 73008, United States
NCT Number: NCT03497091
This is a retrospective review of data documented in medical records.
Looking for future studies?
Notify Me1 year–18 year
All sexes
Observational
Oklahoma City, Oklahoma, 73008, United States
This is a retrospective review of data documented in medical records of patients consuming an amino-acid based enteral formula at a pediatric care facility in the United States.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Enteral Feeding with an amino acid-based formula
Time frame: Up to 12 months before formula switch
Medical diagnosis
Time frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
Body weight in kilograms
Time frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
Length or height (based on age) in centimeters
Time frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
Average of 7 days
Time frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
Average of 7 days
Time frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
Average of 7 days
Time frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
Average of 7 days
Société des Produits Nestlé (SPN)
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04337710
Enteral Feeding Intolerance, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT05265143
Enteral Feeding Intolerance, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03795870
Enteral Feeding Intolerance
Rochester, Minnesota, United States
View Trial DetailsNCT03422900
Brain Diseases, Cardiovascular Diseases
Valladolid, Spain
View Trial Details